#1 Clinical Trials Search in Europe

Fludrocortisone

Fludrocortisone, a synthetic corticosteroid with potent mineralocorticoid activity, is being studied in several clinical trials for its potential benefits in treating various medical conditions. These trials aim to evaluate the drug’s efficacy, safety, and optimal dosing in conditions such as septic shock, sudden hearing loss, orthostatic hypotension, and aneurysmal subarachnoid hemorrhage. By examining fludrocortisone’s effects on blood pressure, sodium retention, and other physiological parameters, researchers hope to expand its therapeutic applications beyond its current approved uses.

Table of Contents

What is Fludrocortisone?

Fludrocortisone, also known by brand names such as Florinef and Flucortac, is a synthetic steroid medication that belongs to a class of drugs called mineralocorticoids[1]. It is a man-made version of a hormone naturally produced by your adrenal glands, which are small glands located on top of your kidneys[2].

This medication is primarily used to treat conditions where the body doesn’t produce enough of its own natural steroid hormones or when there’s an imbalance in the body’s salt and water levels[3].

How Fludrocortisone Works

Fludrocortisone works by mimicking the effects of aldosterone, a natural hormone in your body. Its main functions include:

  • Salt and water retention: It helps your body hold onto salt (sodium) and water, which can increase blood volume and blood pressure[4].
  • Potassium excretion: It increases the amount of potassium your body excretes through urine[5].
  • Blood pressure regulation: By affecting salt and water balance, it can help regulate blood pressure, especially in people who have low blood pressure when standing up (orthostatic hypotension)[6].

Medical Conditions Treated with Fludrocortisone

Fludrocortisone is used to treat several medical conditions, including:

  1. Addison’s Disease: A condition where the adrenal glands don’t produce enough natural steroid hormones[7].
  2. Salt-Losing Adrenogenital Syndrome: A genetic disorder affecting hormone production in the adrenal glands[7].
  3. Orthostatic Hypotension: A form of low blood pressure that occurs when standing up from a sitting or lying position[6].
  4. Septic Shock: A severe condition caused by infection, where fludrocortisone may help improve blood pressure[1].
  5. Subarachnoid Hemorrhage: A type of bleeding in the brain where fludrocortisone may help manage salt and water balance[7].

Researchers are also investigating its potential use in other conditions, such as sudden hearing loss[3] and certain types of fainting (vasovagal syncope)[8].

Dosage and Administration

The dosage of fludrocortisone can vary depending on the condition being treated and the individual patient. Some common dosage forms include:

  • Tablets of 50 micrograms (μg) or 100 micrograms[9]
  • Doses may range from 50 μg to 400 μg per day, often divided into multiple doses throughout the day[6]
  • In some cases, doctors may start with a lower dose and gradually increase it over time[6]

It’s crucial to take fludrocortisone exactly as prescribed by your doctor. Never adjust your dose without consulting your healthcare provider first.

Potential Side Effects

Like all medications, fludrocortisone can cause side effects. Some potential side effects include:

  • Hypokalemia: Low potassium levels in the blood[7]
  • Hypernatremia: High sodium levels in the blood[7]
  • Fluid retention: This can lead to swelling or weight gain[7]
  • High blood pressure[4]
  • Headache
  • Dizziness

Your doctor will monitor you closely for these side effects and may adjust your dose if needed. Always report any unusual symptoms to your healthcare provider.

Ongoing Research and Future Potential

Researchers are continually studying fludrocortisone to understand its full potential. Some areas of ongoing research include:

  • Traumatic Brain Injury: Studies are investigating whether fludrocortisone can help prevent complications in patients with severe brain injuries[5].
  • Septic Shock: Researchers are exploring the optimal dosing of fludrocortisone for patients with septic shock[10].
  • Subarachnoid Hemorrhage: Clinical trials are assessing whether fludrocortisone can improve outcomes in patients with this type of brain bleed[7].
  • Depression: Some studies are looking at how fludrocortisone affects information processing in the brain, which could have implications for depression treatment[2].

These ongoing studies may lead to new applications for fludrocortisone in the future, potentially benefiting more patients with various conditions.

Condition Dosage Key Outcomes Measured Potential Benefits
Septic Shock 50-200 μg daily Time to shock reversal, vasopressor responsiveness Improved vascular response, faster recovery
Sudden Hearing Loss 0.2 mg daily for 30 days Hearing improvement Potential hearing preservation
Orthostatic Hypotension 50-200 μg daily Systolic blood pressure changes Better blood pressure control when standing
Aneurysmal Subarachnoid Hemorrhage 100 μg every 6 hours Modified Rankin Scale score, sodium levels Reduced disability, prevention of hyponatremia

FAQ

  • What is fludrocortisone and how does it work? Fludrocortisone is a synthetic corticosteroid with strong mineralocorticoid activity. It works by promoting sodium and water retention in the body, which can help increase blood volume and blood pressure. This mechanism of action makes it potentially useful in treating conditions involving low blood pressure or salt imbalances.
  • In which medical conditions is fludrocortisone being studied? Clinical trials are investigating fludrocortisone's potential benefits in several conditions, including septic shock, sudden hearing loss, orthostatic hypotension, and aneurysmal subarachnoid hemorrhage. These studies aim to determine if fludrocortisone can improve outcomes in these diverse medical situations.
  • What are the potential side effects of fludrocortisone? Common side effects of fludrocortisone may include hypokalaemia (low potassium levels), hypertension (high blood pressure), and fluid retention. Some studies are specifically monitoring for these effects, as well as potential complications like pulmonary edema. However, in most trials, fludrocortisone appears to be well-tolerated when used at appropriate doses.
  • How is fludrocortisone administered in these clinical trials? The administration of fludrocortisone varies among trials. It is typically given orally, with doses ranging from 50 micrograms to 400 micrograms per day. Some studies use a fixed dose, while others employ a dose escalation approach. The duration of treatment also varies, from a few days to several weeks, depending on the condition being studied.
  • What are the main outcomes researchers are looking at in these fludrocortisone trials? Researchers are examining various outcomes, including changes in blood pressure, resolution of shock in septic patients, improvement in hearing for sudden hearing loss patients, and functional outcomes in patients with subarachnoid hemorrhage. They are also assessing safety profiles, quality of life measures, and physiological parameters such as sodium levels and vascular responsiveness.

Ongoing Clinical Trials on Fludrocortisone

  • Study Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy and Chemotherapy

    Recruiting

    3 1 1 1
    Investigated drugs:
    Austria Czechia Denmark Finland France Germany +8

  • Study Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy

    Recruiting

    3 1 1 1
    Investigated drugs:
    Czechia Estonia France Germany Greece Hungary +9

  • Study of hydrocortisone and fludrocortisone in patients with intermediate/high-risk scheduled cardiac surgery to prevent complications

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study of hydrocortisone and fludrocortisone combination versus placebo in adults with sepsis in intensive care unit to determine corticosteroid response

    Not recruiting

    3 1 1
    Investigated drugs:
    France

  • Study on the Safety and Effectiveness of CRN04894 for Patients with Congenital Adrenal Hyperplasia

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Germany Italy

  • Study on Vilobelimab and Drug Combination for Treating Ulcerative Pyoderma Gangrenosum in Adults

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Hungary Italy The Netherlands +2

Glossary

  • Mineralocorticoid: A type of steroid hormone that helps regulate salt and water balance in the body, primarily by promoting sodium retention and potassium excretion.
  • Septic shock: A life-threatening condition that occurs when sepsis leads to dangerously low blood pressure and abnormalities in cellular metabolism.
  • Hyponatremia: A condition characterized by low sodium levels in the blood, which can cause various symptoms and complications.
  • Vasopressor: A type of medication that causes blood vessels to constrict, thereby increasing blood pressure.
  • Orthostatic hypotension: A form of low blood pressure that occurs when a person stands up from sitting or lying down, often causing dizziness or fainting.
  • Aneurysmal subarachnoid hemorrhage: A type of stroke caused by bleeding into the space surrounding the brain, often due to a ruptured aneurysm.
  • Cerebral vasospasm: A narrowing of brain arteries that can occur as a complication of subarachnoid hemorrhage, potentially leading to stroke.
  • Modified Rankin Scale (mRS): A scale used to measure the degree of disability or dependence in daily activities of people who have suffered a stroke or other neurological disability.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body over time.
  • Placebo: An inactive substance or treatment used in clinical trials as a control to compare against the effects of the drug being studied.

References

  1. https://clinicaltrials.gov/study/NCT04494789
  2. https://clinicaltrials.gov/study/NCT01648998
  3. https://clinicaltrials.gov/study/NCT01186185
  4. https://clinicaltrials.gov/study/NCT02069288
  5. https://clinicaltrials.gov/study/NCT01093261
  6. https://clinicaltrials.eu/trial/study-on-the-effects-of-fludrocortisone-in-treating-neurogenic-orthostatic-hypotension-in-patients/
  7. https://clinicaltrials.gov/study/NCT06409364
  8. https://clinicaltrials.gov/study/NCT00118482
  9. https://clinicaltrials.gov/study/NCT02140918
  10. https://clinicaltrials.gov/study/NCT05001854